Trials / Completed
CompletedNCT01895985
Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male Volunteers
A Single-Center, Open-Label Study Evaluating the Efficacy of Latanoprostene Bunod Ophthalmic Solution 0.024%, in Lowering Intraocular Pressure Over a 24-Hour Period in Japanese Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- Male
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the effect of latanoprostene bunod dosed once daily (QD) in reducing intraocular pressure (IOP) measured over a 24-hour period in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Latanoprostene bunod |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2013-08-01
- Completion
- 2013-10-01
- First posted
- 2013-07-11
- Last updated
- 2018-05-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01895985. Inclusion in this directory is not an endorsement.